!
!
Sign in / Join ICS
Home
Impact of ‘dry days’ on quality of life in patients with ‘wet’ overactive bladder: results of a pooled analysis of three phase III studies with darifenacin
Newman D
1
, Larson-Peters A
2
, Seifu Y
3
, Aronstein W
4
, Mongay L
3
Abstract Category
Quality of Life (QoL)
Abstract 56
Quality of Life & Epidemiology
Scientific Podium Poster Session 6
Thursday 1st October 2009
15:15 - 15:20
Hall C
1.
University of Pennsylvania,
2.
Procter & Gamble Pharmaceuticals,
3.
Novartis Pharmaceuticals Corporation,
4.
CTI Clinical Trial & Consulting Services
Presenter
D
D Newman
University of Pennsylvania
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
03/11/2024 18:57:26